Clınıcal Guıdelines and Its Use In Clinic In Sub Urınary System Symptoms and Pelvic Organ Prolapsus

Öz

Symptoms related to the pelvic floor are a common problem that can be seen in all stages of women's life and have a negative impact on women's quality of life in terms of physical, sexual and social aspects. Guidelines have been developed to be a resource for healthcare services to be provided for the prevention, diagnosis and treatment of these symptoms. These guidelines provide support to healthcare professionals in the process of identifying clinical problems, systematizing them, and creating the necessary suggestions for the solution of the problem with recommendations at different levels of evidence. Current guidelines on lower urinary tract symptoms and pelvic organ prolapse, the importance of anamnesis and physical examination in the initial evaluation of patients, the use of bladder diary and validated scales, post-voiding residual urine volume measurement and urine analysis as the first diagnostic test, application of first-line conservative treatment options, second They agree on using antimuscarinic drugs as a stepwise treatment option and the use of midurethral slings as a surgical method. They agree on testing antimuscarinic drugs and using midurethral slings as a surgical method. Current guidelines and studies with high level of evidence will be guiding in nursing care to be given regarding the symptoms related to the pelvic floor. The aim of this review is to review the guidelines of internationally recognized institutions and organizations on the management of lower urinary system and pelvic organ prolapse symptoms on an evidence-based basis and to raise awareness of the issue among nurses.

Anahtar Kelimeler

• Lower urinary tract symptoms
• clinical guidelines
• pelvic organ prolapse

Alt Üriner Sistem Semptomları ve Pelvik Organ Prolapsuslarında Klinik Rehberler ve Klinikte Kullanımı

Öz

Pelvik tabana ilişkin semptomlar kadın yaşamının her evresinde görülebilen ve kadının yaşam kalitesi üzerinde fiziksel, cinsel, sosyal yönden olumsuz etki yapan yaygın bir sorundur. Bu semptomların önlenmesi, tanısı ve tedavisinde sunulacak sağlık hizmetine kaynak oluşturacak rehberler geliştirilmiştir. Bu rehberler, farklı kanıt düzeyinde öneriler ile klinik sorunları belirleme, sistematize etme, sorunun çözümüne yönelik gerekli önerileri oluşturma sürecinde sağlık profesyonellerine destek sağlamaktadır. Alt üriner sistem semptomları ve pelvik organ prolapsuslarına ilişkin güncel rehberler hastaların ilk değerlendirmesinde anamnez ve fizik muayenenin önemi, mesane günlüğü ve doğrulanmış ölçeklerin kullanımı, ilk tanı testi olarak boşaltım sonrası rezidüel idrar hacmi ölçümü ve idrar analizi yapılması, birinci basamak konservatif tedavi seçeneklerinin uygulanması, ikinci basamak tedavi seçeneği olarak antimuskarinik ilaçların denenmesi, cerrahi yöntem olarak midüretral slinglerin kullanımı konusunda hemfikirdirler. Pelvik tabana ilişkin semptomlara yönelik verilecek hemşirelik bakımında güncel rehberler ve kanıt düzeyi yüksek çalışmalar yol gösterici olacaktır. Bu derlemenin amacı alt üriner sistem ve pelvik organ prolapsusu semptomlarının yönetimi hakkında, alanında uluslararası tanınırlığı olan kurum ve kuruluşların rehberlerini kanıt temelli olarak gözden geçirmek ve hemşirelerde konuyla ilgili farkındalığın artmasını sağlamaktır.

Anahtar Kelimeler

• Alt üriner sistem semptomları
• klinik rehberler
• pelvik organ prolapsusu

Kaynakça

1. 1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function. Report from the standardisation subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178
2. 2. Winters JC, et al., Urodynamic studies in adults: AUA/SUFU guideline. J Urol, 2012. 188(6 Suppl): p. 2464-72.
3. 3. Attia A. Adaptation of international evidence based clinical practice guidelines: The ADAPTE process. Middle East Fertility Society Journal,2013 18(2): 123-126
4. 4. Smiles FB, Mazzei LG, Lopes LC. Critical appraisal of clinical practice guidelines for treatment of urinary incontinence: Protocol for a systematic review. Medicine. 2019. 98:e16698
5. 5. Yang X, Zhang AX,Tan Y, et al. Critical appraisal of clinical practice guidelines for the diagnosis and treatment of stress urinary incontinence using AGREE II instrument: a systematic review protocol. BMJ Open. 2019;9:e030299. doi:10.1136/ bmjopen-2019-030299
6. 6. Medina CA, Costantini E, Petri E et al. Evaluation and surgery for stress urinary incontinence: A FIGO working group report. Neurourol Urodyn. 2017 Feb;36(2):518-528.
7. 7. Sussman RD, Syan R, Brucker BM. Guidelines of the Guidelines: Urinary Incontinence in Women. BJU Int. 2019 Oct 18. doi: 10.1111/bju.14927
8. 8. Abrams P, Andersson KE, Apostolidis A.et al., 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse and Faecal Incontinence. Neurourol Urodyn, 2018. 37(7): p. 2271-2272.

9. 9. Abrams P, Cardozo L, Wagg A, Wein A. (Eds) Incontinence 6th Edition (2017). ICI-ICS. International Continence Society, Bristol UK, ISBN: 978-0956960733.
10. 10. Syan R, Brucker BM, Guideline of guidelines: urinary incontinence. BJU Int, 2016. 117(1): p. 20-33.
11. 11. Nambiar AK, Bosch R, Cruz F.et al. EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence. Eur Urol (2018), https://doi.org/10.1016/j.eururo.2017.12.031
12. 12. Bettez M, Tu LM, Carlson K et al. 2012 update: Guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association. Can Urol Assoc J 2012; 6: 354–63.
13. 13. Corcos J, Przydacz M, Campeau L, et al. CUA guideline on adult overactive bladder. Can Urol Assoc J. 2017;11(5):E142–73. doi: 10.5489/cuaj.4586.
14. 14. Kobashi KC, Albo ME, Dmochowski RR. et al., Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline. J Urol, 2017. 198(4): p. 875-883.
15. 15. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. et al., Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. J Urol, 2019
16. 16. Phillips B, Ball C, Sackett D. Et al. Oxford Centre for Evidence-Based Medicine Levels of Evidence (May 2009). Jeremy Howick March 2009. http://www.cebm.net/index.aspx
17. 17. Evaluation of uncomplicated stress urinary incontinence in women before surgical treatment. Committee Opinion No. 603. The American College of Obstetricians and Gynecologists. Obstet Gynecol 2014; 123:1403–7.
18. 18. Committee on Practice, B.-G. and S. the American Urogynecologic, ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstet Gynecol, 2015. 126(5): p. e66-81.
19. 19. NICE Guidance. Urinary incontinence and pelvic organ prolapse in women: management: NICE (2019) Urinary incontinence and pelvic organ prolapse in women: management. BJU Int, 2019. 123(5): p. 777-803.
20. 20. Zümrütbas AE, Citgez S, Acar Ö et all. The real-life management of overactive bladder: Turkish Continence Society multicenter prospective cohort study with short-term outcome. Neurourol Urodyn. 2019 Nov;38(8):2170-2177. doi: 10.1002/nau.24079. Epub 2019 Jul 23.
21. 21. Drake MJ,Doumouchtsis SK, Hashim H, Gammie A. Fundamentals of urodynamic practice, based on International Continence Society good urodynamic practices recommendations. Neurourol Urodyn. 2018 Aug;37(S6):S50-S60. doi: 10.1002/nau.23773
22. 22. Goldman HB, Lloyd JC, Noblett KL et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018 Jun;37(5):1823-1848. doi: 10.1002/nau.23515. Epub 2018 Apr 11.